Home Health COVID-19 ICU Sufferers Have Excessive Danger of Clots

COVID-19 ICU Sufferers Have Excessive Danger of Clots


By Alan Mozes
HealthDay Reporter

TUESDAY, Oct. 6, 2020 (HealthDay Information) — Hospitalized COVID-19 sufferers face an elevated danger of growing harmful blood clots, a brand new assessment signifies.

The chances of a clot are highest for probably the most critically ailing sufferers. Evaluation of 66 research discovered that 23% of COVID-19 sufferers in an intensive care unit (ICU) developed a blood clot within the leg, generally known as a deep vein thrombosis (DVT).

Total prevalence of a DVT was 14% amongst ICU and non-ICU COVID-19 sufferers, and eight% amongst these with mild-to-moderate illness danger who weren’t admitted to the ICU.

The “numbers are surprisingly excessive compared with different hospitalized sufferers,” mentioned research creator Dr. Cihan Ay.

Of nice concern are blood clots within the legs that may break free and journey to the lungs. This can be a life-threatening situation generally known as pulmonary embolism (PE).

Almost 4% of sufferers not admitted to the ICU developed a pulmonary embolism. And “we discovered a really excessive PE danger of 14% in sufferers handled at an intensive care unit,” mentioned Ay, an affiliate professor in hematology and hemostaseology on the Medical College of Vienna in Austria.

In keeping with the American Coronary heart Affiliation, DVT and PE are every a type of venous thromboembolism, or VTE, as each check with a blood clot that originates in a vein.

VTE is estimated to have an effect on between 300,000 and 600,000 Individuals yearly, the AHA notes. It’s most continuously triggered by surgical procedure, cancer, hospitalization or long-term immobilization.

To look at VTE danger associated to COVID-19, Ay and his colleagues analyzed the findings of 66 research, involving roughly 28,000 COVID-19 sufferers.

On common, the COVID-19 sufferers had been about 63 years outdated, and 6 in 10 had been males. About one-fifth had been admitted to an ICU.

Not one of the research checked out clotting danger amongst COVID-19 sufferers who had not acquired hospital remedy. So the findings don’t communicate to DVT or PE danger amongst such sufferers, mentioned Ay, though “it appears that evidently the chance of clots is low in sufferers with a gentle scientific course of COVID-19.”


Early within the pandemic, it turned clear that blood clot danger appeared elevated in sufferers with COVID-19 in comparison with different ailments. To forestall clotting, “physicians worldwide intensified dosing of blood thinners for COVID-19 sufferers,” Ay mentioned.

This created one other potential drawback, nonetheless, since blood thinners improve the chance of bleeding.

The research authors hope their assessment will supply clinicians extra perception into clotting danger profiles, providing steering as to which sufferers really want preventive clot remedy, Ay mentioned.

As to why COVID-19 would possibly drive up clotting danger within the first place, Ay mentioned consultants can solely speculate primarily based on obtainable knowledge.

“First, the scientific course in such sufferers is usually extreme, which by itself will increase the thrombosis [clotting] danger,” he mentioned. “Second, researchers discovered that COVID-19 interacts with the blood clotting system and the blood vessels, which could clarify the elevated danger in these sufferers.”

Dr. Gregg Fonarow is director of the College of California, Los Angeles Cardiomyopathy Middle. He supplied some extra specifics concerning that interplay.

“The virus SARS-CoV-2 — which causes COVID-19 — has been proven to instantly invade the cells that line blood vessels, endothelial cells,” he famous. “Endothelial damage can result in venous thrombosis.”

As well as, prolonged mattress relaxation or the location of venous catheters throughout remedy for COVID-19 may improve the chance for venous thrombosis, Fonarow famous.

The research outcomes had been printed on-line not too long ago in Analysis and Apply in Thrombosis and Haemostasis.

WebMD Information from HealthDay


SOURCES: Cihan Ay, MD, affiliate professor, scientific division of hematology and hemostaseology, division of drugs, Medical College of Vienna; Gregg Fonarow, MD, director, Ahmanson College of California, Los Angeles Cardiomyopathy Middle;Analysis and Apply in Thrombosis and Haemostasis, Sept. 25, 2020, on-line

Copyright © 2013-2020 HealthDay. All rights reserved.


Please enter your comment!
Please enter your name here